Sale!

ZEROPAIN

Original price was: 630.00৳ .Current price is: 567.00৳ .

  • Short-term pain relief for moderate to severe pain
  • Non-opioid analgesic, acts within 30 minutes
  • Available in oral and injection form
  • Maximum daily dose: 40 mg orally

Generic
Ketorolac Tromethamine

Description
Ketorolac Tromethamine is a non-steroidal anti-inflammatory drug (NSAID) used for the short-term management of moderate to severe pain. It is a potent analgesic and is often prescribed for post-operative pain relief, offering opioid-level pain control.

Benefits

  • Effective short-term pain relief
  • Acts quickly, typically within 30 minutes
  • Suitable alternative to opioids for managing severe pain
  • Can be used both orally and through injection

Ingredients

  • Ketorolac Tromethamine 10 mg

Uses and Doses
For adults, the recommended oral dose is 10 mg every 4-6 hours. The maximum daily dose should not exceed 40 mg. Ketorolac can be administered via injection, with a single dose of 30 mg for IV or 60 mg for IM. It is advised to transition from injection to oral administration as soon as possible. Treatment should not exceed 5 days.

Side Effects
Common side effects include nausea, gastrointestinal bleeding, headache, dizziness, drowsiness, and hypertension. Severe effects can include peptic ulcers, GI bleeding, and renal impairment. Rare, serious side effects include anaphylaxis, stroke, and myocardial infarction.

How to Use
Take Ketorolac Tromethamine as prescribed by your healthcare provider. Do not exceed the recommended dose or duration of therapy. Use the oral form after transitioning from IV or IM treatment, if necessary.

Pregnancy & Lactation
Ketorolac Tromethamine is classified as Pregnancy Category C by the FDA. It should be avoided during pregnancy unless the potential benefits outweigh the risks. It is also excreted in breast milk, so it is not recommended for use while breastfeeding.

Precautions and Warnings
Ketorolac Tromethamine should be used cautiously in elderly patients, individuals with peptic ulcers, GI bleeding, renal impairment, or asthma. It is contraindicated in patients with hypersensitivity to NSAIDs and should not be used in children under 16 years of age.

Safety Information
Keep this medication out of reach of children. Use Ketorolac only for the prescribed duration, and monitor for any signs of gastrointestinal distress or allergic reactions.

Indications
Ketorolac Tromethamine is indicated for the short-term management of moderate to severe acute post-operative pain, where opioid-level analgesia is required.

Pharmacology
Ketorolac works by inhibiting the enzyme cyclooxygenase (COX), reducing the synthesis of prostaglandins, which are responsible for pain and inflammation. While it offers potent pain relief, its anti-inflammatory effects are minimal at standard doses.

Therapeutic Class
Non-opioid analgesics

Storage Conditions
Store in a cool, dry place away from direct sunlight. Keep out of the reach of children.

FAQ

  1. Can I take Ketorolac for more than 5 days?
    No, Ketorolac is only intended for short-term use and should not be taken for more than 5 days.
  2. Can I take Ketorolac if I am pregnant?
    Ketorolac should be avoided during pregnancy unless deemed necessary by a healthcare provider.
  3. Can Ketorolac be taken with other NSAIDs?
    No, taking Ketorolac with other NSAIDs can increase the risk of side effects, particularly gastrointestinal bleeding.

Keywords: Ketorolac, Ketorolac Tromethamine, Zeropain, pain relief, NSAID, Healthcare Pharmaceuticals, post-operative pain, severe pain, oral tablet, injection, short-term pain relief, analgesic, anti-inflammatory, non-opioid, GI bleeding, elderly pain management, opioid alternative, prescription medicine, fast-acting pain relief.

Additional information

Weight 0.2 kg
Dimensions 4 × 2 × 0.5 in
Class -Dosage

Tablet

Size

10mg

Generics

Ketorolac Tromethamine

pharmaceuticals

Healthcare Pharmaceuticals Limited

Reviews

There are no reviews yet.

Be the first to review “ZEROPAIN”

Your email address will not be published. Required fields are marked *